Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting

Overview

Given the potential of semi-quantitative pregnancy tests as part of assisted fertility care, we would like to document the feasibility and acceptability of a semi-quantitative pregnancy test as an adjunct to or replacement of current monitoring protocols to offer women and health care providers a new choice of diagnostic tools to confirm early pregnancy. The pilot will help us to better understand how this tool complements existing monitoring protocols. If a suitable addition, replacement to repeat blood draws for serum hCG assessment, the SQPT could also contribute to efforts to make assisted fertility treatments more patient-friendly. This study seeks to test this innovation by asking women assigned to perform a dBest® semi-quantitative urine panel test (AmeriTekInc, Seattle WA, USA)at home on a weekly basis for up to 4 weeks after embryo transfer. We hypothesize that the test, which can be used at home by women, will provide confirmation of the presence of a pregnancy compared with standard serum hCG testing because 1) it has sensitivity and specificity that correlates well with serum testing, and 2) it can be used at home and thus earlier to determine presence of hCG. Furthermore, a pregnancy can be assured only when a yolksac or embryo could be identified thus women have to wait for a period of 2-3 weeks after the next menses expected. We hypothesize that women seeking assisted fertility treatments will be able to monitor their hCG at home as well. Further, we plan to develop revised instructions to better suit the needs and questions we think would be relevant to women desiring to use this test as part of assisted fertility services. We hypothesize that the simple instructions we will develop for use in this study will enable women to use the test on their own. Provider counseling will complement these instructions and contribute to overall quality of care given to each participant.

Full Title of Study: “Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test to Replace Sequential Serum hCG Testing in an Assisted Fertility Setting”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2013

Interventions

  • Device: Semi-quantitative urine pregnancy test

Arms, Groups and Cohorts

  • Other: Semi-quantitative pregnancy test
    • Semi-quantitative urine pregnancy test (dBest One Step hCG Panel Test Kit)

Clinical Trial Outcome Measures

Primary Measures

  • Document whether continuing pregnancy can be successfully monitored at home using a semi-quantitative pregnancy test
    • Time Frame: 6 weeks

Secondary Measures

  • Feasibility of women using this test at home on their own as a potential future substitute or complement to standard sequential clinic-based visits to monitor pregnancy after embryo transfer.
    • Time Frame: 6 weeks
  • Women’s acceptability of using pregnancy tests at home instead of standard clinic-based monitoring after embryo transfer
    • Time Frame: 6 weeks
  • Assess if written instructions and provider’s counseling enable women using the semi-quantitative pregnancy test at home to understand how it should be used and to correctly interpret the test result
    • Time Frame: 6 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • Eligible for assisted fertility treatment according to hospital guidelines – Agrees to have blood drawn several times for serum hCG tests – Agrees to return for a series of follow-up visits – Willing to follow provider instructions regarding use of at-home pregnancy test – Willing to provide an address and/or telephone number to be contacted for purposes of follow-up – Willing and able to consent to study participation Exclusion Criteria:

  • Women not eligible for assisted fertility treatment – Women who do not agree to have blood drawn several times for serum hCG tests – Women who do not agree return for a series of follow-up visits – Women unable to follow provider instructions regarding use of at-home pregnancy test – Women unable to provide contact information – Women unable to sign the consent form

Gender Eligibility: Female

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Gynuity Health Projects
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Nguyen Thi Nhu Ngoc, MD, Principal Investigator, Center for Research and Consultancy in Reproductive Health
    • Ly Thai Loc, MD, Principal Investigator, Hungvuong Hospital
    • Tara Shochet, PhD, MPH, Principal Investigator, Gynuity Health Projects
    • Paul Blumenthal, MD, MPH, Principal Investigator, Stanford University
    • Beverly Winikoff, MD, MPH, Principal Investigator, Gynuity Health Projects

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.